Sysmex Europe Exhibits New Products and Innovative Concepts in Infection Diagnostics at EUROMEDLAB 2022
|
By LabMedica International staff writers Posted on 11 Apr 2022 |
|
Sysmex Europe (Norderstedt, Germany) presented new products and innovative concepts in infection diagnostics at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place in Munich, Germany, from 10 to 14 April 2022. In addition to presenting its latest products at the exhibition on a spacious booth, Sysmex Europe underpinned its role as a leading solution and knowledge provider by hosting three educational workshops, plus a variety of further live sessions in a dedicated presentation area.
Sysmex Europe continued supporting the event as a gold sponsor. With a two-storey booth of 128 m2 exhibition space on the ground floor and a further 40 m2 consulting area on the upper floor, Sysmex Europe showcased its competence in the fields of clinical value, workflow automation and digital services, including solutions for new business areas. In line with the brand’s key message of ‘Lighting the way with diagnostics’, Sysmex Europe has the laboratory as well as the clinician and patient in mind and looks at the bigger picture beyond the individual analyser. To strengthen its position further, the company aims at expanding its perception in new business areas while maintaining or increasing the level of trust and loyalty of their existing customers.
Visitors saw a range of new products and innovative concepts on the booth. Besides principal exhibits for the core lab areas such as hematology, haemostasis and urinalysis, and life science solutions for fecal testing, novel highlights were the XQ-320 hematology analyzer, the BloodScience Workcell, the latest clinical flow cytometry solution featuring the XF-1600, and the digital services Caresphere XQC and Sysmex Academy app. Sysmex Europe’s philosophy extends beyond the product itself, and knowing that support and continuous education is of equal importance for a rewarding user experience, the company hosted three 60-minute educational workshops within the congresses’ program, focusing on the clinical value of infection diagnostics from POC to hematology, lean workflow using Sysmex automation concept solutions, and smartening today’s laboratories by means of digital technology and services. To reach a wider audience, these on-site workshops were streamed live via Vimeo on the company’s LinkedIn channel.
Last but not least, an additional range of live lectures and ‘Meet the expert’ sessions including external speakers – in person or virtually – took place in loose succession on the company’s booth in the ‘live presentation area’ using a large, curved screen of approx. 7 x 2.5 m size. All sessions were recorded and are made available on the Sysmex Europe website, while some of these are being additionally shown via the livestream channel.
Related Links:
Sysmex Europe
Latest EUROMEDLAB 2022 News
- Sebia Displays Automated, High Throughput Capillary Electrophoresis (CE) Instruments at EUROMEDLAB 2022
- Snibe Showcases Maglumi X3 Fully Automatic CLIA System at EUROMEDLAB 2022
- Thermo Fisher Presents Cascadion SM Clinical Analyzer and LC-MS IVD Medical Devices at EUROMEDLAB 2022
- Binding Site Exhibits Special Protein Analyzer Optilite at EUROMEDLAB 2022
- DIRUI Presents High-End Diagnostic Systems for Hospitals and High-Volume Labs at EUROMEDLAB 2022
- DIESSE Diagnostica Demonstrates Advanced Immunoassay and ESR Analyzers at EUROMEDLAB 2022
- Gentian Diagnostics Exhibits Assays for Wide Range of Clinical Chemistry Platforms at EUROMEDLAB
- Ortho Presents Broad Menu of High-Performing Assays at EUROMEDLAB 2022
- Technopath Highlights Laboratory Solutions to Enhance QC Efficiencies at EUROMEDLAB 2022
- Mindray Demonstrates Latest IVD Innovations at EUROMEDLAB 2022
- LumiraDx Presents LumiraDx Point of Care Instrument at IFCC EUROMEDLAB
- Beckman Coulter Presents Virtual Showcase of Laboratory Solutions at EUROMEDLAB 2022
- Horiba Showcases Latest Hematology and Hemostasis Solutions at EUROMEDLAB 2022
- Roche Showcases the Future of Diagnostic Solutions at EUROMEDLAB 2022
- Siemens Showcases Broad Portfolio of Integrated IVD Solutions at EUROMEDLAB Munich
- EUROMEDLAB 2022 Showcases Breakthrough Technologies and Cutting Edge Scientific Advances in Clinical Lab Diagnostics
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more